Keeping Score at the FDA

The U.S. Food and Drug Administration’s performance in its review of new drug applications varies widely depending on the therapeutic area involved, according to a new report from the California Healthcare Institute and the Boston Consulting ...

GSK Goes Hostile

Pharma keeps offer at $13 per share and goes directly to shareholders. GlaxoSmithKline rebuffed Human Genome Sciences’ offer to participate in its strategic alternatives review process and instead went directly to shareholders in a bid to acquire the ...

Use of Avastin for Eye Disease Could Save NHS $136 Million Annually

Trial pitting Avastin against Lucentis finds they yield similar results for wet-AMD. The U.K.’s National Health Service could save $136 million (£84.5 million) annually by treating patients who have wet age-related macular degeneration with Avastin instead of Lucentis ...

Salk scientists redraw the blueprint of the body's biological clock

IMAGE: Satchidananda Panda is an associate professor in the Regulatory Biology Laboratory. Ron Evans is a professor in the Gene Expression Laboratory. Click here for more information. ...

Inner weapons against allergies: Gut bacteria control allergic diseases

PHILADELPHIA — When poet Walt Whitman wrote that we "contain multitudes," he was speaking metaphorically, but he was correct in the literal sense. Every human being carries over 100 trillion individual bacterial cells within the intestine -- ten times more cells than comprise the body ...

JAMA commentary contends vitamin therapy can still reduce stroke

President's Bioethics Commission releases report on human subjects protection

AZ, GSK ask carmakers for directions amid pharma breakdown

David Berry: Renewable Petroleum from Microbes

David Berry is sitting in a midtown Manhattan coffee shop, taking a break from a carbon-trading conference across the street, when a news report on the wall-mounted television catches his ...

Jeffrey Bode:Peptide "Legos" to Make New Drugs

 The market for protein-based drugs, such as insulin and human growth hormone, has doubled over the last five years, to more than $50 billion. But making therapeutic proteins is difficult. ...

2011 October Highlights

2nd World Pharmacogenomics Summit 2011  October 25-27, 2011 |  Munich, Germany  The 2nd World Pharmacogenomics Summit is the perfect place for individuals focusing on biomarkers, drug safety/efficacy or clinical decision making to discover best practise in ...

2011 September Highlights

HUPO 10th Annual World Congress  September 4-7, 2011 | Geneva, Switzerland  HUPO 10th Annual World Congress, combined with 5th EuPA Annual Scientific Meeting and the 8th SPS scientific meeting, will be held in Geneva, Switzerland. The Scientific Program ...

2011 August Highlights

International Conference & Exhibition on Cancer Science & Therapy  15-17 August 2011 |  Las Vegas, USA OMICS Group invites all the participants across the globe to attend International Conference & Exhibition on Cancer Science & Therapy during 15-17 August 2011 Las ...

Andor Deep-Depletion CCD Camera Captures Advance That Could Speed-Up Introduction Of Stem Cell Therapy

Many medical researchers believe that stem cell therapy will revolutionise the treatment of human disease and may provide treatments for many currently incurable diseases. However, one problem still to be ...

NEW Capnograph For Small Rodents & Respiratory Mechanics

Harvard Apparatus-Hugo Sachs Electronik is proud to introduce the Type 340 Capnograph for small rodents. This extremely low dead space Capnograph makes it suitable for mice as well as other ...

Hyglos Introduces EndoLISA®, The World’s First ELISA-Based Endotoxin Detection Method

Hyglos today has the pleasure to present EndoLISA®, the world’s first commercially available ELISA-based endotoxin detection method. EndoLISA® is the result of several years of research and test development aimed at ...

Why did healthy children fall critically ill in the 2009 H1N1 flu pandemic?

Largest study to date finds co-infection with MRSA increased death risk 8-fold; Flu vaccination urged Boston, Mass. -- During the 2009 H1N1 influenza pandemic, many previously healthy children ...

Tracking Swine Flu Vaccination Rates And Attitudes Via Twitter

A unique and innovative analysis of how social media can affect the spread of a disease has been designed and implemented by a scientist at Penn State University studying attitudes ...

Journal names discovery that HIV treatment can prevent spread 'breakthrough of the year'

Johns Hopkins researchers key part of team recognized for its scientific findings The finding of a team of researchers — including several members from Johns Hopkins ...

Sanofi (France) Taps David Meeker as New CEO of Genzyme Corporation

PARIS--(BUSINESS WIRE)--Sanofi (EURONEXT: SAN and NYSE: SNY) announced today the appointment of David Meeker as Chief Executive Officer of Genzyme, a Sanofi company, effective November 1, 2011. ...

Abbott Laboratories's Absorb(TM) Bioresorbable Vascular Scaffold Honored with Wall Street Journal Technology Innovation Award

Abbott (NYSE: ABT) announced that the investigational ABSORB bioresorbable vascular scaffold (BVS) has been recognized as the winner of the Medical Devices category in the 2011 Wall Street Journal Technology ...

Warner C. Greene: focuses on the pathogenic interplay of the HIV-1 and HTLV-I human retroviruses with immune cells.

My laboratory focuses on the pathogenic interplay of the HIV-1 and HTLV-I human retroviruses with immune cells. Infection of human hosts with these retroviruses produces contrasting diseases within the CD4 subset of T lymphocytes, specifically the Acquired Immune Deficiency Syndrome (AIDS) with HIV-1 and the Adult T-cell Leukemia (ATL) with ...

Indiana Clinical and Translational Science Institute HUB: A model for collaboration

TGen, Karmanos Lead $6M Melanoma Project

Sanford-Burnham Medical Research Institute and Pfizer Collaborate to Speed Drug Discovery

e2v aerospace and defense and Maxim Announce an Agreement to Extend the Product Life of Maxim Ceramic ICs

Syntaxin and Ipsen Ally to Develop Botulinum Toxin Therapeutics

BioAmber and LANXESS Partner for Renewable, Phthalate-free Plasticizers

NHGRI Unveils New-Look Genome Sequencing Program; Plans $416M in Funding

NYU to Study Genetics of Obesity-Related Cancers

Researchers Get NHGRI Funding to Study Effects of Alzheimer's Risk Testing

Venture Firms Pump $18M into Fledgling Arteaus Therapeutics

Servier and miRagen Sign $352M Deal for Cardiovascular miRNA Therapeutics

Tetraphase Awarded Initial $6M by NIAID to Develop Antibiotic Against Biothreats